27
Topic 1.
Identification of High-risk Localized and Locally-advanced Prostate Cancer
第三次
臺灣晚期攝護腺癌專家共識
3 rd Taiwan Advanced Prostate Cancer Consensus
空格結果≧75%（達到St. Gallen共識）標示黃底紅字；空格結果≧50%標示紅字。
Survey URO RO MO High Vol Senior UO N
Option 1 Option 2 Option 3
175 27%
66%
6%
46 16%
71%
13%
30 56%
36%
8%
96 20%
71%
9%
95 23%
68%
9%
30 17%
73%
10%
國內專家仍參考國際治療指引(EAU, NCCN)對於Localized high-risk and locally advanced的 定義。根據NCCN (2018 vision 2)指出，影像檢查應在偵測或分類疾病時，做為選擇治療 或改變治療的依據。台灣多數醫師主張，必須根據影像學檢查，才能得到較可信的臨床 分期，以供下一步治療規畫依據。
•評論分析：
How do you identify high-risk localized and locally advanced prostate cancer?
Survey Panelists 240
28%
64%
8%
11
38
11%
84%
5%
0 Responders
1. Based on risk classification as proposed by major international guidelines (EAU, AUA, NCCN…) only, do not order image study routinely
2. Order image studies (multi-parametric MRI, cross-sectional
abdomino-pelvic imaging, bone scan) for all prostate cancer patients 3. Order image studies only for high-risk/very high-risk prostate cancer patients
Non-responder, abstain, unqualified to answer
Q1-1
28
